Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
Clinical trial NCT04774809 · TERMINATED
Trial details
- NCT number
- NCT04774809
- Sponsor
- Reistone Biopharma Company Limited
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2022-03-21
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.